A postdoctoral position is immediately available in the Laboratory of Cancer Epigenetics headed by François Fuks (ULB – Université Libre de Bruxelles/Open University of Brussels, Belgium).
You will be expected to conduct cancer research in epigenetics and epigenomics. Specifically, you will investigate the mechanisms and functions of a novel epigenetic modification. The following recent publication has direct relevance to this project: Delatte B, et al., Science. 2016; 351:282-5).
Genetic, biochemical and cell biological as well as genome-wide approaches (e.g. RNA-Seq, ChIP-Seq, Infinium Methylation) will be applied. The lab is running a Next Gen Sequencing Illumina platform (EPICS http://epics.ulb.be/), it is part of the ULB-Cancer Research Center (U-CRC) directed by Prof. Fuks, and provides an excellent scientific environment to conduct high profile research.
We are looking for highly motivated candidates with considerable experience of molecular and cell biology. Applicants should hold a PhD degree in Biochemistry/Molecular Biology or related disciplines (or have recently submitted their thesis with their defence scheduled) and have published (or about to publish) in a peer reviewed journal. Experience of advanced RNA techniques would be an advantage.
Although not required, suitable candidates will be highly encouraged to apply for (inter)national funding during employment as part of their development towards independence for which sufficient help is available within the team.
The position is funded for 3 years. Screening of applications begins immediately and continues until an outstanding candidate is selected. Flexible starting date.
Informal enquiries, CV and names of two referees should be send to: Valentina Albarani (email@example.com)
Please quote reference PD20160611 on your application and in any correspondence about this vacancy.
Lab website: http://www.ulb.ac.be/medecine/fukslab
– Delatte et al. Science 2016
– Delatte et al. Science Rep. 2015
– Boumahdi et al. Nature 2014
– Deplus et al. Cell Rep. 2014
– Delatte et al. EMBO J. 2014
– Deplus et al. EMBO J. 2013
– Volkmar et al. EMBO J. 2012
– Dedeurwaerder et al. EMBO Mol Med. 2011
– Fuks F. Nature. 2010
– Epsztejn-Litman Nat Struct Mol Biol. 2008
– Villa et al. Cancer Cell. 2007
– Brenner & Fuks Dev Cell. 2007
– Viré et al. Nature 2006
– Brenner et al. EMBO J. 2005